Next, we analyzed the correlation between TRIM25 expression and prognosis of breast cancer patients treated with PTX, and found that the breast cancer patients treated with PTX with lower expression of TRIM25 had a longer overall survival (Fig. 8F). Here, TRIM25 is linked to breast carcinoma.